메뉴 건너뛰기




Volumn 45, Issue 5, 2006, Pages 602-609

LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE; PROTEIN P53; TAMOXIFEN;

EID: 33746723489     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600660811     Document Type: Article
Times cited : (19)

References (27)
  • 1
    • 0037221767 scopus 로고    scopus 로고
    • TP53 and breast cancer
    • Borresen-Dale AL. TP53 and breast cancer. Hum Mutat 2003;21:292-300.
    • (2003) Hum Mutat , vol.21 , pp. 292-300
    • Borresen-Dale, A.L.1
  • 2
    • 0033885192 scopus 로고    scopus 로고
    • TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
    • Overgaard J, Yilmaz M, Guldberg P, Hansen LL, Alsner J. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer. Acta Oncol 2000;39:327-33.
    • (2000) Acta Oncol , vol.39 , pp. 327-333
    • Overgaard, J.1    Yilmaz, M.2    Guldberg, P.3    Hansen, L.L.4    Alsner, J.5
  • 3
    • 0033766175 scopus 로고    scopus 로고
    • Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
    • Alsner J, Yilmaz M, Guldberg P, Hansen LL, Overgaard J. Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin Cancer Res 2000;6:3923-31.
    • (2000) Clin Cancer Res , vol.6 , pp. 3923-3931
    • Alsner, J.1    Yilmaz, M.2    Guldberg, P.3    Hansen, L.L.4    Overgaard, J.5
  • 4
    • 0027983669 scopus 로고
    • Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
    • Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994;265:346-55.
    • (1994) Science , vol.265 , pp. 346-355
    • Cho, Y.1    Gorina, S.2    Jeffrey, P.D.3    Pavletich, N.P.4
  • 5
    • 0030448650 scopus 로고    scopus 로고
    • Identification of a novel p53 functional domain that is necessary for efficient growth suppression
    • U S A
    • Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A 1996;93:15335-40.
    • (1996) Proc Natl Acad Sci , vol.93 , pp. 15335-15340
    • Walker, K.K.1    Levine, A.J.2
  • 7
    • 0033744152 scopus 로고    scopus 로고
    • p53 codon 72 polymorphism as a risk factor in the development of breast cancer
    • Papadakis EN, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun 2000;3:389-92.
    • (2000) Mol Cell Biol Res Commun , vol.3 , pp. 389-392
    • Papadakis, E.N.1    Dokianakis, D.N.2    Spandidos, D.A.3
  • 8
    • 0642314312 scopus 로고    scopus 로고
    • P53 codon 72 polymorphism in breast cancer
    • Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep 2003;10:711-4.
    • (2003) Oncol Rep , vol.10 , pp. 711-714
    • Buyru, N.1    Tigli, H.2    Dalay, N.3
  • 9
    • 1542546270 scopus 로고    scopus 로고
    • Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer
    • Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, et al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 2003;10:307-11.
    • (2003) Breast Cancer , vol.10 , pp. 307-311
    • Huang, X.E.1    Hamajima, N.2    Katsuda, N.3    Matsuo, K.4    Hirose, K.5    Mizutani, M.6
  • 10
    • 2942627405 scopus 로고    scopus 로고
    • Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women
    • Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Lett 2004;210:197-203.
    • (2004) Cancer Lett , vol.210 , pp. 197-203
    • Noma, C.1    Miyoshi, Y.2    Taguchi, T.3    Tamaki, Y.4    Noguchi, S.5
  • 11
    • 10744231895 scopus 로고    scopus 로고
    • No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients
    • Mabrouk I, Baccouche S, El Abed R, Mokdad-Gargouri R, Mosbah A, Said S, et al. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci 2003;1010:764-70.
    • (2003) Ann N Y Acad Sci , vol.1010 , pp. 764-770
    • Mabrouk, I.1    Baccouche, S.2    El Abed, R.3    Mokdad-Gargouri, R.4    Mosbah, A.5    Said, S.6
  • 13
  • 14
    • 1642576139 scopus 로고    scopus 로고
    • Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features
    • Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, et al. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res 2004;10:124-30.
    • (2004) Clin Cancer Res , vol.10 , pp. 124-130
    • Han, W.1    Kang, D.2    Park, I.A.3    Kim, S.W.4    Bae, J.Y.5    Chung, K.W.6
  • 15
    • 0036911840 scopus 로고    scopus 로고
    • The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
    • Langerod A, Bukholm IR, Bregard A, Lonning PE, Andersen TI, Rognum TO, et al. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidemiol Biomarkers Prev 2002;11:1684-8.
    • (2002) Cancer Epidemiol Biomarkers Prev , vol.11 , pp. 1684-1688
    • Langerod, A.1    Bukholm, I.R.2    Bregard, A.3    Lonning, P.E.4    Andersen, T.I.5    Rognum, T.O.6
  • 16
    • 0036606622 scopus 로고    scopus 로고
    • Effect of germ-line genetic variation on breast cancer survival in a population-based study
    • Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002;62:3052-7.
    • (2002) Cancer Res , vol.62 , pp. 3052-3057
    • Goode, E.L.1    Dunning, A.M.2    Kuschel, B.3    Healey, C.S.4    Day, N.E.5    Ponder, B.A.6
  • 17
    • 10744224153 scopus 로고    scopus 로고
    • Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients
    • Bonafe M, Ceccarelli C, Farabegoli F, Santini D, Taffurelli M, Barbi C, et al. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients. Clin Cancer Res 2003;9:4860-4.
    • (2003) Clin Cancer Res , vol.9 , pp. 4860-4864
    • Bonafe, M.1    Ceccarelli, C.2    Farabegoli, F.3    Santini, D.4    Taffurelli, M.5    Barbi, C.6
  • 18
    • 0030058617 scopus 로고    scopus 로고
    • The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
    • Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996;88:173-82.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 173-182
    • Sjogren, S.1    Inganas, M.2    Norberg, T.3    Lindgren, A.4    Nordgren, H.5    Holmberg, L.6
  • 19
    • 0035866772 scopus 로고    scopus 로고
    • Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer
    • Geisler S, Lonning PE, Aas T, Johnsen H, Fluge O, Haugen DF, et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res 2001;61:2505-12.
    • (2001) Cancer Res , vol.61 , pp. 2505-2512
    • Geisler, S.1    Lonning, P.E.2    Aas, T.3    Johnsen, H.4    Fluge, O.5    Haugen, D.F.6
  • 20
    • 27144536311 scopus 로고    scopus 로고
    • p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer
    • Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, et al. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Clin Cancer Res 2005;11:7328-33.
    • (2005) Clin Cancer Res , vol.11 , pp. 7328-7333
    • Xu, Y.1    Yao, L.2    Ouyang, T.3    Li, J.4    Wang, T.5    Fan, Z.6
  • 21
    • 0346003770 scopus 로고    scopus 로고
    • Chalkley estimates of angiogenesis in early breast cancer-relevance to prognosis
    • Offersen BV, Sorensen FB, Yilmaz M, Knoop A, Overgaard J. Chalkley estimates of angiogenesis in early breast cancer-relevance to prognosis. Acta Oncol 2002;41:695-703.
    • (2002) Acta Oncol , vol.41 , pp. 695-703
    • Offersen, B.V.1    Sorensen, F.B.2    Yilmaz, M.3    Knoop, A.4    Overgaard, J.5
  • 22
    • 0031961112 scopus 로고    scopus 로고
    • Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement
    • Hansen LL, Andersen J, Overgaard J, Kruse TA. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. APMIS 1998;106:371-7.
    • (1998) APMIS , vol.106 , pp. 371-377
    • Hansen, L.L.1    Andersen, J.2    Overgaard, J.3    Kruse, T.A.4
  • 23
    • 0032523969 scopus 로고    scopus 로고
    • Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer
    • Hansen LL, Yilmaz M, Overgaard J, Andersen J, Kruse TA. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 1998;58:2166-9.
    • (1998) Cancer Res , vol.58 , pp. 2166-2169
    • Hansen, L.L.1    Yilmaz, M.2    Overgaard, J.3    Andersen, J.4    Kruse, T.A.5
  • 24
    • 0038148257 scopus 로고    scopus 로고
    • Rapid, accurate genotyping of beta-thalassaemia mutations using a novel multiplex primer extension/denaturing high-performance liquid chromatography assay
    • Wu G, Hua L, Zhu J, Mo QH, Xu XM. Rapid, accurate genotyping of beta-thalassaemia mutations using a novel multiplex primer extension/denaturing high-performance liquid chromatography assay. Br J Haematol 2003;122:311-6.
    • (2003) Br J Haematol , vol.122 , pp. 311-316
    • Wu, G.1    Hua, L.2    Zhu, J.3    Mo, Q.H.4    Xu, X.M.5
  • 27
    • 0036330489 scopus 로고    scopus 로고
    • Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients
    • Hogdall EV, Hogdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, et al. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients. Anticancer Res 2002;22:1859-64.
    • (2002) Anticancer Res , vol.22 , pp. 1859-1864
    • Hogdall, E.V.1    Hogdall, C.K.2    Christensen, L.3    Glud, E.4    Blaakaer, J.5    Bock, J.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.